Sinoway Industrial Co., Ltd.

Rivaroxaban 366789-02-8 Rivaroxaban 366789-02-8

Rivaroxaban 366789-02-8
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Rivaroxaban :

Name

Rivaroxaban

Alias

(S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;RIVAROXABAN STAGE-IV [5-CHLORO-N-({5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2(AS PER INV;Rivaroxaban Isomer;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;BAY 59-7939; 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide

CAS NO.

366789-02-8

Molecular Formula

C19H18ClN3O5S

Molecular Weight

435.88

Brief Introduction

Rivaroxaban is an oral, bioavailable Factor Xa inhibitor that selectively blocks the active site of Factor Xa and does not require a cofactor (eg, antithrombin III) to exert activity. Activation of factor X by factor Xa (FXa) by endogenous and exogenous pathways plays an important role in the coagulation cascade.

Rivaroxaban dose-dependently inhibits factor Xa activity in humans, with dose-dependent prolongation of prothrombin time (PT), activated partial thromboplastin time (aPTT), and HepTest® heparin quantitative determination using Neoplastin® reagent. Anti-factor Xa activity is also affected by rivaroxaban.

Storage condition

Room temperature, seal.


Use of Rivaroxaban:

Adult patients undergoing elective hip or knee replacement surgery to prevent venous thromboembolism (VTE)

COA of Rivaroxaban :

Items

Standard

Results

Appearance

White or almost white powder

White powder

Melting point

229~ 234℃

230.0~231.5℃

Residue on ignition

NMT0.1%

0.03%

Related substances


Any other impurity: NMT0.2%

Total of impurity: NMT0.5 %

0.1%

0.19%

Loss on drying

NMT1.0%

0.13%

Heavy metal

NMT20ppm

Conforms

Purity

More than 99.50%

99.81%

Conclusion: The results show that the product complies with the Enterprise standard.

* Products under the patent are only for R&D use.

  • Imatinib Mesylate 220127-57-1
    Basic information of Imatinib Mesylate:NameImatinib MesylateAliasGLIVEC;GLEEVEC;IMATINIB METHANESULFONATE; CGP-57148B; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)a... Imatinib Mesylate 220127-57-1
  • Budesonide 51333-22-3
    Basic information:Product Name: BudesonideMolecular Formula : C25H34O6Molecular Weight: 430.53CAS No.: 51333-22-3Appearance: White or almost white crystalline powderSpecifications:EP8.0Usages :It used to ... Budesonide 51333-22-3
  • Olmesartan Medoxomil 144689-63-4/144689-78-1
    Basic information of Olmesartan Medoxomil:NameOlmesartan MedoxomilMolecular FormulaC24H26N6O3Molecular Weight446.5Quality StandardI.H.SPackage Size25kg/drumBrief IntroductionOlmesartan medoxomil is an... Olmesartan Medoxomil 144689-63-4/144689-78-1
  • Ketanserin 74050-98-9
    Basic information of KetanserinNameKetanserin CAS NO.74050-98-9Molecular Formula C22H22FN3O3Quality StandardEP / 99% minGrade StandardMedicine gradePackage Size1kg packingUse of KetanserinKetanserin ... Ketanserin 74050-98-9

MORE_DETAIL Rivaroxaban 366789-02-8

Basic information of Rivaroxaban :

Name

Rivaroxaban

Alias

(S)-Rivaroxaban;(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;RIVAROXABAN STAGE-IV [5-CHLORO-N-({5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-1,3-OXAZOLIDIN-5-YL}-METHYL)-2(AS PER INV;Rivaroxaban Isomer;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;BAY 59-7939; 5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide

CAS NO.

366789-02-8

Molecular Formula

C19H18ClN3O5S

Molecular Weight

435.88

Brief Introduction

Rivaroxaban is an oral, bioavailable Factor Xa inhibitor that selectively blocks the active site of Factor Xa and does not require a cofactor (eg, antithrombin III) to exert activity. Activation of factor X by factor Xa (FXa) by endogenous and exogenous pathways plays an important role in the coagulation cascade.

Rivaroxaban dose-dependently inhibits factor Xa activity in humans, with dose-dependent prolongation of prothrombin time (PT), activated partial thromboplastin time (aPTT), and HepTest® heparin quantitative determination using Neoplastin® reagent. Anti-factor Xa activity is also affected by rivaroxaban.

Storage condition

Room temperature, seal.


Use of Rivaroxaban:

Adult patients undergoing elective hip or knee replacement surgery to prevent venous thromboembolism (VTE)

COA of Rivaroxaban :

Items

Standard

Results

Appearance

White or almost white powder

White powder

Melting point

229~ 234℃

230.0~231.5℃

Residue on ignition

NMT0.1%

0.03%

Related substances


Any other impurity: NMT0.2%

Total of impurity: NMT0.5 %

0.1%

0.19%

Loss on drying

NMT1.0%

0.13%

Heavy metal

NMT20ppm

Conforms

Purity

More than 99.50%

99.81%

Conclusion: The results show that the product complies with the Enterprise standard.

* Products under the patent are only for R&D use.
Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//